Quintrio
Home

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Electra Therapeutics, Inc. Common stock

ETRA

Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.

Last trade $8.53
Day change +$0.22 (+2.65%)
Day range $8.07 – $9.40
Volume 235,077
Market cap $522M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for ETRA.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for ETRA, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026
Revenue$0
Cost of revenue$0
Gross profit$0
Selling, general and administrative$7.79M
Research and development$17.27M
Total operating expenses$25.06M
Operating income-$25.06M
Interest expense$0
Income before taxes-$23.93M
Income taxes$0
Net income-$23.93M
Net income attributable to common shareholders-$23.93M
EBITDA-$25.06M
Basic earnings per share-$3.47
Diluted earnings per share-$3.47

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Kinzey Capital Management: Electra Sets Nasdaq IPO Terms

Electra Therapeutics is pricing 21.7 million shares at $14-$16 each on Nasdaq under ticker ETRA, targeting up to $347 million to advance ipsoprubart through its SURPASS registration trial for secondary haemophagocytic lymphohistiocytosis. The offering values the clinical-stage antibody developer near $1 billion, with frontline data showing 100% overall survival at eight weeks versus historical 20-30% mortality rates.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.